These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18391203)

  • 41. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    Cohen JI; Picchio GR; Mosier DE
    J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular target genes of Epstein-Barr virus nuclear antigen 2.
    Maier S; Staffler G; Hartmann A; Höck J; Henning K; Grabusic K; Mailhammer R; Hoffmann R; Wilmanns M; Lang R; Mages J; Kempkes B
    J Virol; 2006 Oct; 80(19):9761-71. PubMed ID: 16973580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
    J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
    Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
    EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.
    Ito S; Ikeda M; Kato N; Matsumoto A; Ishikawa Y; Kumakubo S; Yanagi K
    Virology; 2000 Jan; 266(1):110-9. PubMed ID: 10612665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
    J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5.
    Pokrovskaja K; Mattsson K; Kashuba E; Klein G; Szekely L
    J Gen Virol; 2001 Feb; 82(Pt 2):345-358. PubMed ID: 11161273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein.
    Cecchini MJ; Dick FA
    Biochem J; 2011 Mar; 434(2):297-308. PubMed ID: 21143199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.
    Hwang SG; Lee D; Kim J; Seo T; Choe J
    J Biol Chem; 2002 Jan; 277(4):2923-30. PubMed ID: 11713253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E
    J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells.
    Kashuba E; Mattsson K; Pokrovskaja K; Kiss C; Protopopova M; Ehlin-Henriksson B; Klein G; Szekely L
    Int J Cancer; 2003 Jul; 105(5):644-53. PubMed ID: 12740913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.